Gyrolab™ Assay Development Centre of Excellence
Rapid, low volume, high-throughput immunoassay development, optimisation and transfer support.
The Gyrolab™ system from Gyros Protein Technologies is one of the most widely used high-throughput immunoassay platforms in pharma development. Its compact disc (CD) microfluidic format enables rapid assays with very small sample volume requirements.
Fleet Bioprocessing is a Gyrolab Certified Assay Transfer and Development Partner, offering assay development, transfer and optimisation services for users of the Gyrolab platform.
We apply our industry leading expertise in all aspects of immunoassay design, development and validation to pharma development applications.
Fleet’s renowned bioconjugation expertise allows us to offer reproducible and cost-effective supply of critical reagents for use in Gyrolab assays, including fluorescent and biotinylated antibodies.
Low Sample Volume
Minimal sample and reagent consumption reduces cost and conserves material.
High Throughput
Up to 112 data points per CD, with five CDs run unattended in less than an hour each.
Fast Assay Workflow
Automated, walk-away workflows deliver results in hours not days
Assay Transfer Support
Seamless method transfer to client or CRO labs with ongoing optimisation support.
Gyrolab™ Platform Benefits
Your Gyrolab™ Assay Development Partner
With more than 25 years of immunoassay expertise, Fleet Bioprocessing combines scientific depth with Gyrolab platform capability to move projects from concept to confident data more efficiently.
Our Service Includes
Custom Assay Design & Development
Method Transfer to Client or CRO Labs
Flexible throughput on Gyrolab xP Platform
Integrated Critical Reagent & Conjugate Support
Applications
Anti-Drug Antibody (ADA) & Custom Immunoassays
Antibody Screening & Ranking
Bioprocessing & Cell Culture Media Analysis
Gyrolab™ Projects
Real World Solutions. Reliable Results.
Gyrolab Assay Development Programme for CRO Use
A suite of validated immunoassays developed for a variety of commonly encountered analytes to support easy adoption of the platform by CROs.
Gyrolab Assay for Viral Protein in Cell Culture Media
Fleet developed a transferable Gyrolab assay method for quantifying viral capsid protein in cell culture media. The assay was compatible with the client’s required sample types and suitable for routine analysis at their own facilities. Compared with the ELISA kit previously used, the Gyrolab method reduced reagent use, sample consumption and analyst time. Fleet continues to support the assay with supplies of critical conjugate.
Gyrolab Assay for a Novel Bispecific Antibody
Using the Gyrolab platform, Fleet developed a rapid assay for a novel bispecific antibody biopharmaceutical. The assay required only small volumes of valuable sample and provided a dynamic range suitable for preclinical toxicokinetic analysis with a single dilution step. The method was readily transferred to the CRO performing the preclinical study for validation, with Fleet continuing to support the assay through the supply of additional critical reagent batches.
Why Work With Fleet?
Gyrolab™ Assay Development Centre of Excellence
25+ Years Developing Immunoassays
In-House Custom Conjugation Expertise
Support Tailored to Your Programme
